Chelsea Mannebach, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 |
Mrs. Kristen Hyde, PHARM D, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 W Franklin Rd, Boise, ID 83705 Phone: 208-429-6433 Fax: 208-429-6427 |
Dr. Dennis W Nelson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 999 N Curtis Rd Ste 102, Boise, ID 83706 Phone: 208-367-2167 Fax: 208-367-3915 |
Brooke Nicole Elliott, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7020 W State St, Boise, ID 83714 Phone: 208-853-3503 |
Chelsea Zipse, PHARMD Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 1055 N Curtis Rd, Boise, ID 83706 Phone: 208-367-2772 |
Riley Suzanne Binkowski Pharmacist - Ambulatory Care Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1086 |
Karina Garcia, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 909 E Parkcenter Blvd, Boise, ID 83706 Phone: 208-338-3722 |
Dr. Katie Jindrich, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1219 S Broadway Ave, Boise, ID 83706 Phone: 208-433-9905 |
Shelby Maclauren Lawrence, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 |
Kristin Cleverdon, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 500 W Fort St, Boise, ID 83702 Phone: 208-422-1000 |
Dr. Jennifer Nicole Lashinsky, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-2490 |
Debra Mackenzie Pharmacist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-5026 |
Alyssa M Perry, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6565 W Emerald St, Boise, ID 83704 Phone: 208-514-2512 |
Mr. London Reiber, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 W Franklin Rd, Boise, ID 83705 Phone: 208-429-6433 Fax: 208-429-6427 |
Dr. Rico Lynn Pelazini, PHARM D, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6725 N Glenwood St, Boise, ID 83714 Phone: 208-319-1271 Fax: 208-319-1274 |
Steven E Seyfert, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10751 W Overland Rd, Pharmacy Department, Boise, ID 83709 Phone: 208-373-5233 Fax: 208-373-5227 |
Shannon Mars, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 660 E Boise Ave, Boise, ID 83706 Phone: 208-336-8340 Fax: 208-336-0985 |
Michael Hembree Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1219 S Broadway Ave, Boise, ID 83706 Phone: 208-433-9905 |
Dr. Layne Thomas Tominaga, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 190 E Bannock St, Boise, ID 83712 Phone: 208-381-7069 Fax: 208-381-4355 |
Meagan T Wakefield, PHARMD Pharmacist - Oncology Medicare: Not Enrolled in Medicare Practice Location: 100 E Idaho St, Boise, ID 83712 Phone: 208-381-3108 |
News Archive
A new method to standardize the reporting of radiation dose volumes in the use of four-dimensional computed tomography (4D-CT) can lead to a more accurate radiation dose to the lungs in lung cancers, thereby lowering the risk of lung injury, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
Despite recent advances in diagnosis and treatment, the prognosis of patients with biliary tract cancer is still poor. Elucidating the biological characteristics of these carcinomas has become necessary to improve the prognosis of patients and to devise better treatment strategies. A recent study report that invasive front dominant expression of LNγ2 and LNβ3 and active MMP7 play a key role in the progression of biliary tract cancer.
An ancient spice, long used in traditional Asian medicine, may hold promise for the prevention of both rheumatoid arthritis and osteoporosis, according to a recently completed study at The University of Arizona College of Medicine.
Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its Phase 2 diabetes clinical trial, designed to determine the minimum dose of D-tagatose capable of reducing HbA1c, found that the minimum dose capable of affecting HbA1c (7.5 g three-times daily, or TID) was within the range of doses tested
› Verified 9 days ago